D.A. Davidson & Co’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-3,833
Closed -$14K 2316
2017
Q2
$14K Sell
3,833
-2,900
-43% -$10.6K ﹤0.01% 1943
2017
Q1
$27K Buy
6,733
+1,035
+18% +$4.15K ﹤0.01% 1748
2016
Q4
$24K Buy
5,698
+331
+6% +$1.39K ﹤0.01% 1875
2016
Q3
$52K Buy
5,367
+200
+4% +$1.94K ﹤0.01% 1513
2016
Q2
$29K Buy
5,167
+1,430
+38% +$8.03K ﹤0.01% 1632
2016
Q1
$28K Hold
3,737
﹤0.01% 1608
2015
Q4
$49K Sell
3,737
-19,439
-84% -$255K ﹤0.01% 1400
2015
Q3
$381K Sell
23,176
-1,343
-5% -$22.1K 0.01% 618
2015
Q2
$550K Buy
+24,519
New +$550K 0.02% 547